Holen Sie sich die Stockscreener-App
2.265
0.66%
-0.015
Schlusskurs vom Vortag:
$2.28
Offen:
$2.25
24-Stunden-Volumen:
152.71K
Relative Volume:
0.11
Marktkapitalisierung:
$1.80B
Einnahmen:
$10.00M
Nettoeinkommen (Verlust:
$-29.47M
KGV:
-11.32
EPS:
-0.2
Netto-Cashflow:
$-21.55M
1W Leistung:
+1.12%
1M Leistung:
-11.52%
6M Leistung:
-39.11%
1J Leistung:
-22.70%
1-Tages-Spanne:
$2.2005
$2.275
1-Wochen-Bereich:
$2.185
$2.33
52-Wochen-Spanne:
$1.575
$5.02
Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile
Firmenname
Mereo Biopharma Group Plc Adr
Sektor
Branche
Telefon
4403330237300
Adresse
ONE CAVENDISH PLACE, LONDON
Vergleichen Sie MREO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MREO
Mereo Biopharma Group Plc Adr
|
2.265 | 346.62M | 10.00M | -29.47M | -21.55M | -0.20 |
|
ONC
Beigene Ltd Adr
|
240.81 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.33 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.33 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.00 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.26 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-27 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-06 | Eingeleitet | Jefferies | Buy |
| 2024-06-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-10-13 | Fortgesetzt | BTIG Research | Buy |
| 2022-08-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-05-05 | Eingeleitet | BTIG Research | Buy |
| 2021-04-05 | Eingeleitet | Needham | Buy |
Alle ansehen
Mereo Biopharma Group Plc Adr Aktie (MREO) Neueste Nachrichten
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
Mereo BioPharma Group plc SEC 10-Q Report - TradingView
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights - GlobeNewswire
Mereo Biopharma Group Plc ADR (MREO) can make a big difference with a little luck - Sete News
Analyzing Mereo Biopharma Group Plc ADR (MREO) After Recent Trading Activity - knoxdaily.com
How should investors view Mereo Biopharma Group Plc ADR (MREO)? - uspostnews.com
Analytical Overview: Mereo Biopharma Group Plc ADR (MREO)’s Ratios Tell a Financial Story - DWinneX
Balance Sheet Insights: Halliburton Co (HAL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
INN’s latest rating updates from top analysts. - knoxdaily.com
EVLV’s 2023 Market Dance: Down -10.63% – Time to Invest? - investchronicle.com
Mereo Biopharma Group Plc ADR: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Mereo Biopharma Group Plc ADR [MREO] Shares Fall -0.78 % on Thursday - knoxdaily.com
Brookdale Senior Living Inc [BKD] Records 50-Day SMA of $5.84 - knoxdaily.com
VST Stock Sees Surge of Approximately 7.21% in Last Five Days - knoxdaily.com
Core & Main Inc [NYSE: CNM] Sees Increase in Stock Value - knoxdaily.com
This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO) - Sete News
Financial Metrics Check: B. Riley Financial Inc (RILY)’s Ratios for Trailing Twelve Months - DWinneX
Mereo Biopharma Group Plc ADR [MREO] Investment Appeal on the Rise - knoxdaily.com
Freeport-McMoRan Inc [FCX] Stock sold by Insider Robertson Maree E. for $0.58 million - knoxdaily.com
D.R. Horton Inc (DHI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Insider Sale Alert: Genworth Financial Inc [GNW] – Is it Time to sell? - knoxdaily.com
Mereo Biopharma Group Plc ADR (MREO) requires closer examination - uspostnews.com
SMX (Security Matters) Plc (SMX) shows promising results - uspostnews.com
Should investors be concerned about Uranium Energy Corp (UEC)? - uspostnews.com
Is Aquestive Therapeutics Inc (AQST) worth investing in despite its overvalued state? - uspostnews.com
Are Dave & Buster’s Entertainment Inc (PLAY) shares a good deal now? - uspostnews.com
EOLS Stock Sees Decline of Approximately -17.34% in Last Five Days - knoxdaily.com
There is no way Allarity Therapeutics Inc (ALLR) can keep these numbers up - Sete News
Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges - Investing.com India
C3is Inc Inc. (CISS) Price Performance Over the Years: A Comparative Study - investchronicle.com
Microchip Technology, Inc [MCHP] Stock sold by Insider Bjornholt James Eric for $0.23 million - knoxdaily.com
Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough - Investing.com India
Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.25 - Investing.com India
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights - GlobeNewswire
Mereo BioPharma Secures 3-Year Cash Runway While Pushing Phase 3 Studies Forward - Stock Titan
Closing Bell Recap: WANG & LEE Group Inc (WLGS) Ends at 0.43, Reflecting a -42.70 Downturn - The Dwinnex
Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock? - MSN
ARS Pharmaceuticals outlines 2025 growth strategy with neffy commercialization and global expansion - MSN
Mereo BioPharma’s SWOT analysis: setrusumab, alvelestat drive rare disease stock potential - Investing.com India
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - Barchart
How Do Things Look For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) In The Short-Term? - Stocks Register
Mereo BioPharma stock hits 52-week low at $2.52 By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.52 - Investing.com India
Prepare Yourself for Liftoff: Mereo Biopharma Group Plc ADR (MREO) - SETE News
There is no doubt that OrganiGram Holdings Inc (OGI) ticks all the boxes. - SETE News
Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News
Recent Insider Activity Could Benefit Mereo Biopharma Group Plc ADR (MREO) - Knox Daily
Analyzing Digital Turbine Inc (APPS) After Recent Trading Activity - Knox Daily
Finanzdaten der Mereo Biopharma Group Plc Adr-Aktie (MREO)
Umsatz
Nettogewinn
Free Cashflow
ENV
13.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):